Using the EHR to Advance Genomic Medicine Across a Diverse Health System
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- University of Pennsylvania
- Study ID
- NCT06377033
- Status
- Recruiting
Conditions
- ALS
- Alzheimer Disease
- Cardiomyopathy Non-ischemic
- Frontotemporal Dementia
- Genetic Predisposition
- Paraganglioma
- Parkinson Disease
- Pheochromocytoma
- Polyneuropathies
- Thoracic Aortic Aneurysm
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Behavioral nudge — BEHAVIORALComparison of genetic rates among individuals for whom it may make a difference in their care across study arms.
Study Details
Given the expansion of indications for genetic testing and our understanding of conditions for which the results change medical management, it is imperative to consider novel ways to deliver care beyond the traditional genetic counseling visit, which are both amenable to large-scale implementation and sustainable. The investigators propose an entirely new approach for the implementation of genomic medicine, supported by the leadership of Penn Medicine, investigating the use of non-geneticist clinician and patient nudges in the delivery of genomic medicine through a pragmatic randomized clinical trial, addressing NHGRI priorities. Our application is highly conceptually and technically innovative, building upon expertise and infrastructure already in place. Innovative qualities of our proposal include: 1) Cutting edge EHR infrastructure already built to support genomic medicine (e.g., partnering with multiple commercial genetic testing laboratories for direct test ordering and results reporting in the EHR); 2) Automated EHR-based direct ordering or referring by specialist clinicians (i.e., use of replicable modules that enable specialist clinicians to order genetic testing through Epic Smartsets, including all needed components, such as populated gene lists, smartphrases, genetic testing, informational websites and acknowledgement e-forms for patient signature); 3) EHR algorithms for accurate patient identification (i.e., electronic phenotype algorithms to identify eligible patients, none of which currently have phenotype algorithms present in PheKB; 4) Behavioral economics-informed implementation science methods: This trial will be the first to evaluate implementation strategies informed by behavioral economics, directed at clinicians and/or patients, for increasing the use of genetic testing; further it will be the first study in this area to test two forms of defaults as a potential local adaptation to facilitate implementation (ordering vs. referring); and 5) Dissemination: In addition to standard dissemination modalities,PheKB95, GitHub and Epic Community Library, the investigators propose to disseminate via AnVIL (NHGRI's Genomic Data Science Analysis, Visualization, and Informatics Lab-Space). Our results will represent an entirely new paradigm for the provision of genomic medicine for patients in whom the results of genetic testing change medical management.
Key Dates
- Start date
- Jun 10, 2024
- Status verified
- Jul 2025
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 1,000 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- FACTORIAL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Active Comparator: Generic BPA; no nudgeUsual care
- Active Comparator: Clinician nudge, orderClinician will receive a nudge to order genetic testing for the patient.
- Active Comparator: Clinician nudge, referClinician will receive a nudge to refer the patient for genetic testing.
- Active Comparator: Patient nudgeThe patient will receive a text message encouraging them to speak with their clinician about genetic testing.
- Active Comparator: Clinician BPA order plus patient nudgeClinician will receive a nudge to order genetic testing for the patient and the patient will receive a text message encouraging them to speak with their clinician about genetic testing.
- Active Comparator: Clinician BPA refer plus patient nudgeClinician will receive a nudge to refer patient for genetic testing and the patient will receive a text message encouraging them to speak with their clinician about genetic testing.
Primary Outcome Measure
Rate of Genetic Testing [ Time Frame: 3 years ]
Central Contacts
- Benita Weathers, MPH2155738860
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Penn Medicine | Philadelphia | Pennsylvania | 19104 |
Find similar trials in Philadelphia, PA
Related Studies
- Phenotype, Genotype & Biomarkers in ALS and Related DisordersEnrolling By Invitation · University of Miami · Palo Alto, California
- Longitudinal Early-onset Alzheimer's Disease Study ProtocolRecruiting · Indiana University · Sun City, Arizona
- Deep Brain Stimulation (DBS) Retrospective Outcomes StudyRecruiting · Boston Scientific Corporation · Phoenix, Arizona
- Abbott DBS Post-Market Study of Outcomes for Indications Over TimeRecruiting · Abbott Medical Devices · Tucson, Arizona